Cosmetic Surgery Today

Plastic Surgery News, Costs of Cosmetic Surgery and Elective Procedures Blog

FDA Pushes for Product Labeling on Dermal Fillers

Posted by Cosmetic Surgery Review on November 28, 2008

While millions of men and women continue turn to injectable fillers to say goodbye to facial wrinkles and achieve a more youthful, sculpted look, experts say that not all dermal fillers are created equal.

Popular fillers such as Juvederm, Artefill, Sculptra and Restylane are becoming the quick-fix solution for many patients who don’t want to undergo facelift surgery.

Fillers made with hyaluronic acid are proving to be especially popular with baby boomers and the younger generations because they pose few risks and side effects.  However, the FDA has recently received a number of complaints and reports of unexpected side effects from several areas of the country and is currently investigating popular fillers such as Juvederm and Restylane.

The FDA panel is considering adding a requirement for all dermal filler manufacturers so that all products are clearly marked with a warning lable.  Currently, each box of the dermal fillers is marked with only a few sentences about potential side effects of the treatment.  The FDA may soon be requiring more explicit details, but many plastic surgeons and company representatives are arguing that this is an unnecessary mandate.

Fillers are convenient, affordable, and can provide instant results for those who have  fine lines and wrinkles forming around the eyes and mouth, or have sagging skin around the cheeks. They are quickly becoming a non-surgical alternative in the form of the ‘Liquid Facelift’ where surgeons use a combination of different fillers to sculpt and tighten key facial compartments.

The jury is out on whether the FDA will win its case about the extra reporting, but consumers are still encouraged to do their research and make sure they understand all of the potential side effects of even non-invasive and ‘safe’ treatments.  Finding a licensed surgeon and making sure they have a few years of experience with administering dermal fillers can also reduce the risk of adverse side effects.



2 Responses to “FDA Pushes for Product Labeling on Dermal Fillers”

  1. […] Here is the original post:  FDA Pushes for Product Labeling on Dermal Fillers « Cosmetic … […]

  2. Body Makeover california said

    This is simply brilliant! I didn’t know that was possible. Stumbled it for you.

    -Alexis Scott

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: